Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
about
Key Targets for Multi-Target Ligands Designed to Combat NeurodegenerationDrug candidates in clinical trials for Alzheimer's disease.Changes in Histidine Decarboxylase, Histamine N-Methyltransferase and Histamine Receptors in Neuropsychiatric Disorders.Knockout of histamine receptor H3 alters adaptation to sudden darkness and monoamine levels in the zebrafish.
P2860
Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Histamine H3 Receptor Antagoni ...... zed Placebo-Controlled Trials.
@ast
Histamine H3 Receptor Antagoni ...... zed Placebo-Controlled Trials.
@en
type
label
Histamine H3 Receptor Antagoni ...... zed Placebo-Controlled Trials.
@ast
Histamine H3 Receptor Antagoni ...... zed Placebo-Controlled Trials.
@en
prefLabel
Histamine H3 Receptor Antagoni ...... zed Placebo-Controlled Trials.
@ast
Histamine H3 Receptor Antagoni ...... zed Placebo-Controlled Trials.
@en
P2093
P2860
P356
P1476
Histamine H3 Receptor Antagoni ...... zed Placebo-Controlled Trials.
@en
P2093
Momoko Kubo
Shinji Matsunaga
Taro Kishi
P2860
P304
P356
10.3233/JAD-150393
P50
P577
2015-09-03T00:00:00Z